Lineage Cell Therapeutics
  • Company
    • About Us
    • Leadership
    • Board of Directors
    • Careers
    • Contact
  • Products & Pipeline
    • OpRegen®
    • OPC1
    • VAC2
  • Technologies
    • Cell Therapy
    • Other Technologies
      • Vision Restoration Programs
      • MS/Stroke Programs
      • HyStem® Delivery Technology
      • Renevia®
    • Patents & Trade Secrets
    • Scientific Publications
  • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
      • Committee Composition
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
    • Financials & Filings
      • SEC Filings
      • Annual Report and Proxy Information
      • 2018 AgeX Form 10 and Information Statement
      • 2019 Form 8937
    • E-mail Alerts
    • Contact IR
  • Menu

  • The future of cell therapy

    Lineage is a clinical-stage biotechnology company developing novel cell therapies

    Company OverviewCorporate Presentation

  • The future of cell therapy

    Lineage is a clinical-stage biotechnology company developing novel cell therapies

    Company OverviewCorporate Presentation
© Copyright - Lineage Cell Therapeutics, Inc.   |   Terms of Use & Privacy   |   [email protected]
  • Facebook
  • Twitter
  • Linkedin
Scroll to top

Welcome back!

is now

We recently launched a new identity to reflect our commitment to becoming a leading cell therapy company. Please update your bookmarks and explore our new look!